FDA Expands Biktarvy® Indication for HIV Treatment

- Biktarvy Now First and Only INSTI-Based Single-Tablet Regimen That is FDA Approved and DHHS Guideline Recommended for People Who are Virologically ...

February 27, 2024 | Tuesday | News
Tevogen Bio Launches Genetic Predisposition Study for Long COVID Treatment Advancements

Tevogen Bio Holdings Inc. ('Tevogen Bio') (Nasdaq: TVGN) announces its strategic initiative to advance research into Long COVID treatment, unveiling plans ...

February 21, 2024 | Wednesday | News
Roche Diagnostics and BioPorto Announce Expanded Collaboration

    ProNephro AKI (NGAL) stands out as the first AKI biomarker test to secure FDA clearance for pediatric use, covering children from...

February 20, 2024 | Tuesday | News
Bayer AG and AskBio Initiate Phase II Trial of AB-1002 Gene Therapy for Congestive Heart Failure

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announ...

February 19, 2024 | Monday | News
CMR Surgical Appoints Industry Veteran to Lead Operations in Asia Pacific, Middle East, and Africa

CMR Surgical (CMR), a global leader in surgical robotics, has announced the appointment of Sushobhan Dasgupta as President and Chief Commercial Officer for...

February 19, 2024 | Monday | News
Roche Collaborates with PathAI to Enhance Digital Pathology Capabilities for Companion Diagnostics

PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion...

February 13, 2024 | Tuesday | News
PatenSee and Fresenius Medical Care Sign Clinical Collaboration Agreement

Under the agreement, the parties will first collaborate in a joint, multi-center, pilot trial of PatenSee's contactless monitoring system in Fresenius Medi...

February 13, 2024 | Tuesday | News
Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage

  Viz.ai, a pioneering force in AI-driven disease detection and intelligent care coordination, has attained a significant milestone with the receipt ...

February 12, 2024 | Monday | News
NICE Issues Final Draft Guidance: ILUVIEN® Access Expanded for Diabetic Macular Edema Patients

NICE Final Draft Guidance recommends providing National Health System (NHS) patients with a phakic lens access to the only sustained-release treatment last...

February 08, 2024 | Thursday | News
Sapient Extends Multi-Omics Services with High Throughput Discovery Proteomics

Sapient, a biomarker discovery organization providing bespoke services for multi-omics data generation and analysis, has announced the roll-out of its high...

February 07, 2024 | Wednesday | News
QIAGEN's QIAstat-Dx Meningitis/Encephalitis Panel Secures HSA Approval, Advancing Syndromic Testing in Singapore

  Meningitis, characterized by inflammation of the protective membranes enveloping the brain and spinal cord, poses a grave medical emergency due to ...

February 07, 2024 | Wednesday | News
Revvity Introduces Cutting-Edge Solutions for Diagnostics and Life Sciences at SLAS2024

 The company's commitment to advancing human potential through science is evident in its transformative approach and a diverse portfolio of specialize...

February 05, 2024 | Monday | News
Nikon Expands Global BioImaging Network with New Labs in USA and Japan

Nikon Instruments Inc. (Nikon) is pleased to announce the establishment of the Nikon BioImaging Lab Lexington in Massachusetts, USA, where it will provide ...

January 29, 2024 | Monday | News
Sanofi's Dupixent® FDA Approved as First and Only Treatment for Children (1+) with Eosinophilic Esophagitis (EoE

Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared to placebo&nbs...

January 26, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close